Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36627 | Lysine-specific Demethylase Inhibitor (1C) (hydrochloride) | ||
Lysine-specific demethylase inhibitor (1C) (LSD inhibitor (1C)) is an inhibitor of LSD1, a repressive demethylase selective for histone H3 lysine 4 (H3K4).1,2LSD inhibitor (1C) inhibits LSD1 activity by 85.9% when used at a concentration of 10 μM.1It increases the level of H3K4 methylation, including H3K4me1 and H3K4me2 but not H3K9me2 levels, in HCT116 human colon carcinoma cells.2LSD inhibitor (1C) also induces re-expression of the Wnt signaling pathway proteins secreted frizzle-related protei... | |||
T6835 |
Fenoldopam mesylate
Fenoldopam methanesulfonate,SKF-82526 mesylate,Corlopam mesylate,mesylate,SKF 82526,非诺多泮甲磺酸盐 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Fenoldopam mesylate (Corlopam mesylate) 是一种多巴胺受体D1选择性激动剂。 | |||
T4418 |
GSK2879552 2HCl (1401966-69-5(free base))
|
Histone Demethylase | Chromatin/Epigenetic |
GSK2879552 2HCl (1401966-69-5(free base)) 是一种口服的、不可逆的赖氨酸特异性去甲基化酶 1 (LSD1) 抑制剂,具有潜在的抗肿瘤活性。 | |||
T7942 |
Tranylcypromine hemisulfate
Tranylcypromine Sulfate,Tranylcypromine (hemisulfate),反苯环丙胺半硫酸盐 |
Histone Demethylase; MAO; Monoamine Oxidase | Chromatin/Epigenetic; Metabolism; Neuroscience |
Tranylcypromine hemisulfate (Tranylcypromine Sulfate) 是单胺氧化酶(MAO) 和赖氨酸特异性去甲基化酶 1 (LSD1) 的抑制剂,可用于研究抑郁症和子宫内膜异位症。 | |||
T83966 |
LSD1-IN-30
|
Histone Demethylase | Chromatin/Epigenetic |
LSD1-IN-30 是赖氨酸特异性脱甲基酶 1 (LSD1) 抑制剂,具有抗癌活性,可用于研究小细胞肺癌和急性髓细胞白血病。 | |||
T21652 |
RN-1 dihydrochloride
|
Histone Demethylase; MAO | Chromatin/Epigenetic; Metabolism; Neuroscience |
RN-1 dihydrochloride 是血脑屏障通透性的、不可逆的赖氨酸特异性脱甲基酶 1 (LSD1) 选择性抑制剂,IC50为 70 nM,对 LSD1 的选择性高于 MAO-A 和 MAO-B,IC50分别为 0.51 μM 和 2.785 μM。 | |||
T11882 |
Pulrodemstat benzenesulfonate
LSD1-IN-7 benzenesulfonate,CC-90011 benzenesulfonate |
Histone Demethylase | Chromatin/Epigenetic |
Pulrodemstat benzenesulfonate (CC-90011 benzenesulfonate) 是一种有效的口服活性赖氨酸特异性去甲基化酶 1 (LSD1) 抑制剂,IC50为 0.25 nM,具有抗癌活性。它诱导急性髓细胞性白血病和小细胞肺癌细胞分化,对 LSD2、MOA-A 和 MAO-B 的酶抑制作用较小。 | |||
T6362 |
Domatinostat
4SC202,4SC 202,4SC-202 (free base),4SC-202 |
Apoptosis; HDAC | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Domatinostat (4SC202) 是一种 I 型 HDAC 抑制剂,能够抑制 HDAC1、HDAC2和 HDAC3 的活性,IC50值分别为 1.20 μM、1.12 μM 和 0.57 μM,同时能够抑制组蛋白赖氨酸特异性脱甲基酶1 的活性。 | |||
T4477 |
Domatinostat tosylate
4SC-202 tosylate,4SC-202 |
Apoptosis; HDAC | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Domatinostat tosylate (4SC-202) 是一种 I 型 HDAC 抑制剂,能够抑制 HDAC1、HDAC2和 HDAC3 的活性,IC50值分别为 1.20 μM、1.12 μM 和 0.57 μM。它也抑制组蛋白赖氨酸特异性脱甲基酶1 的活性。 | |||
T39252L |
5-[(1S,2S)-2-[(Cyclopropylmethyl)amino]cyclopropyl]-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide hydrochloride
|
Others | Others |
5-[(1S,2S)-2-[(Cyclopropylmethyl)amino]cyclopropyl]-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide hydrochloride 是一种环丙酶化合物,可作为赖氨酸特异性脱甲基酶-1抑制剂,可用于精神分裂症、发育障碍和神经退行性疾病。 | |||
T13056 | T-448 free base | Histone Demethylase | Chromatin/Epigenetic |
T-448 free base is a specific, orally active and irreversible lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) inhibitor(IC50 of 22 nM). | |||
T13057 |
T-448
|
Histone Demethylase | Chromatin/Epigenetic |
T-448 is a specific, orally active and irreversible lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) inhibitor(IC50 of 22 nM). | |||
T11883 |
Pulrodemstat Methylbenzenesulfonate
LSD1-IN-7 Methylbenzenesulfonate |
Others | Others |
LSD1-IN-7 Methylbenzenesulfonate is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity. | |||
T39226 |
INCB059872
INCB059872 |
||
INCB059872 is a highly potent, orally active, selective, and irreversible inhibitor of Lysine-Specific Demethylase 1 (LSD1). Its chemical properties make it suitable for use in researching myeloid leukemia. | |||
T13052 |
S2101
S 2101 |
Histone Demethylase | Chromatin/Epigenetic |
S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s). | |||
T11880 | LSD1-IN-5 | Histone Demethylase | Chromatin/Epigenetic |
LSD1-IN-5 increases dimethylated Lys4 of histone H3, shows no effect on expression of LSD1. LSD1-IN-5 is a potent and reversible inhibitor of lysine-specific demethylase 1 (LSD1), with an IC50 of 121 nM. | |||
T11881 | LSD1-IN-6 | Histone Demethylase | Chromatin/Epigenetic |
LSD1-IN-6 increases dimethylated Lys4 of histone H3, shows no effect on expression of LSD1. LSD1-IN-6 is a potent and reversible inhibitor of lysine-specific demethylase 1 (LSD1), with an IC50 of 123 nM. | |||
T60361 | LSD1/2-IN-4 | ||
LSD1/2-IN-4 是一种 PCPA 衍生物,是 LSD1 和 LSD2 的抑制剂。LSD1/2-IN-4 对 LSD1 和 LSD2 具有抑制作用,其Ki 值分别为 0.11 μM 和 130 μM。LSD1/2-IN-4 可用于多种癌症的研究,如 T 细胞急性淋巴细胞白血病 (TALL) 。 | |||
T63935 | Bomedemstat hydrochloride | ||
Bomedemstat (IMG-7289) hydrochloride 是一种口服具有活力的、不可逆的 lysine-specific demethylase 1(LSD1) 抑制剂。Bomedemstat hydrochloride 能够增加 H3K4 和 H3K9 的甲基化,并改变基因表达。Bomedemstat hydrochloride 能够抑制癌细胞增殖并诱导细胞凋亡,表现出抗癌效果。 | |||
T36625 |
LSD1/HDAC6-IN-1
LSD1/HDAC6-IN-1 |
||
LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1]. | |||
T40420 |
Namoline
|
||
Namoline is a γ-pyrone compound that functions as a selective and reversible inhibitor of Lysine-specific demethylase 1 (LSD1) with an IC50 of 51 μM in an HRP-coupled enzymatic assay. By impairing LSD1 demethylase activity, Namoline effectively inhibits cell proliferation. Due to its characteristics, Namoline holds promise for research pertaining to androgen-dependent prostate cancer. | |||
T61565 | KDM5B-IN-3 | ||
KDM5B-IN-3 (Compound 5) is an inhibitor of histone lysine-specific demethylase 5B (KDM5B) or JARID1B. It effectively inhibits the activity of KDM5B with an IC50 value of 9.32 μM. Consequently, KDM5B-IN-3 serves as a valuable tool in gastric cancer research [1]. | |||
T11503 |
GSK 690 Hydrochloride
|
Histone Demethylase | Chromatin/Epigenetic |
GSK 690 (Hydrochloride) 是一种可逆的赖氨酸特异性去甲基化酶1 (LSD1)抑制剂,Kd 值为 9 nM,IC50值为 37 nM。 | |||
T60362 | LSD1-IN-22 | ||
LSD1-IN-22 是一种有效的赖氨酸特异性去甲基化酶 1 (LSD1) 抑制剂(Ki= 98 nM)。LSD1-IN-22 对某些癌细胞具有抗增殖活性。 | |||
T69937 |
INCB059872 tosylate
|
||
INCB059872, also known as INCB59872, is a potent, selective, and orally active lysine-specific demethylase 1 inhibitor. INCB059872 binds to and inhibits LSD1, a demethylase that suppresses the expression of target genes by converting the di- and mono-methylated forms of lysine at position 4 of histone H3 (H3K4) to mono- and unmethylated H3K4, respectively, through amine oxidation. LSD1 inhibition enhances H3K4 methylation and increases the expression of tumor-suppressor genes. In addition, LSD... | |||
T39799 |
S2157
S2157 |
||
S2157, a potent N-alkylated tranylcypromine (TCP) derivative lysine-specific demethylase 1 (LSD1) inhibitor, enhances H3K9 methylation and concurrently reduces H3K27 acetylation at super-enhancer sites. This compound triggers apoptosis in TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells by inhibiting NOTCH3 and TAL1 gene expression. Moreover, S2157 is capable of crossing the blood-brain barrier, effectively eliminating central nervous system (CNS) leukemia in mice models implanted... | |||
T70008 |
Bomedemstat ditosylate
|
||
Bomedemstat, also known as IMG-7289, is a lysine-specific histone demethylase 1 (LSD1) inhibitor with antineoplastic activity. Bomedemstat may be useful in the treatment of acute myeloid leukaemia, myelodysplastic syndrome, and Myelofibrosis. IMG-7289 selectively inhibited proliferation and induced apoptosis of JAK2 V617F cells by concomitantly increasing expression and methylation of p53, and, independently, the pro-apoptotic factor PUMA and by decreasing the levels of its antiapoptotic antago... | |||
T39800 |
S2116
|
||
S2116 is a powerful inhibitor of lysine-specific demethylase 1 (LSD1), and it is a derivative of N-alkylated tranylcypromine (TCP). S2116 exhibits its inhibitory effects by increasing H3K9 methylation and inducing reciprocal H3K27 deacetylation at super-enhancer regions. In TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells, S2116 triggers apoptosis by repressing the transcription of NOTCH3 and TAL1 genes. Furthermore, S2116 demonstrates significant growth retardation of T-ALL cells... | |||
T39258 |
Pulrodemstat
LSD1-IN-7,CC-90011 |
||
Pulrodemstat (CC-90011) is a highly potent and selective inhibitor of lysine specific demethylase-1 (LSD1). It exhibits a reversible mode of action and can be administered orally. With an impressive IC50 of 0.25 nM, Pulrodemstat effectively suppresses the enzymatic activity of LSD1. Notably, it demonstrates minimal inhibition against LSD2, MOA-A, and MAO-B enzymes. Moreover, Pulrodemstat possesses remarkable anticancer properties, promoting differentiation in acute myeloid leukemia (AML) and sma... | |||
T62674 | LSD1-IN-21 | ||
LSD1-IN-21 是一种有效的、具有血脑屏障通透性的 LSD1 (赖氨酸特异性去甲基化酶-1) 抑制剂 (IC50: 0.956 μM)。LSD1-IN-21 能够明显减少促炎细胞因子 TNF-α,表现出良好的抗癌和抗炎效果。 | |||
T60360 | LSD1/2-IN-3 | ||
LSD1/2-IN-3 是赖氨酸特异性去甲基化酶 1 (LSD1) 的选择性抑制剂,Ki 值是 11 nM,而对LSD2的 Ki 值为 7 μM。LSD1在肿瘤干细胞中异常表达,LSD1/2-IN-3 能够抑制LSD1活性和癌细胞增殖。 | |||
T9634 | Bomedemstat | ||
Bomedemstat (IMG-7289) 是一种有效的,具有口服活性的且不可逆的赖氨酸特异性脱甲基酶 1 (LSD1) 抑制剂,具有表观遗传活性。Bomedemstat 具有抗癌活性,可用于急性髓性白血病 (AML) 和骨髓纤维化 (MF) 的研究。 |